Patents by Inventor Joseph S. Podolski

Joseph S. Podolski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions with trans-clomiphene
    Patent number: 7368480
    Abstract: The present invention relates to the use of compositions comprising trans-clomiphene for treating men with hypogonadism. The invention is also directed to methods for treating males with hypogonadism. The present invention is also directed to methods of decreasing cholesterol levels.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: May 6, 2008
    Assignee: Repros Therapeutics Inc.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
    Patent number: 7173064
    Abstract: The present invention discloses compositions and methods useful for treating wasting, especially a loss of muscle mass. The present invention also discloses compositions and methods useful for treating lipodystrophy. The compositions and methods of the present invention are particularly beneficial to HIV-infected individuals.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: February 6, 2007
    Assignee: Repros Therapeutics Inc.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • Methods and materials for the treatment of testosterone deficiency in men
    Publication number: 20040241224
    Abstract: The present invention relates to the use of compositions comprising trans-clomiphene for treating men with hypogonadism. The invention is also directed to methods for treating males with hypogonadism.
    Type: Application
    Filed: July 2, 2004
    Publication date: December 2, 2004
    Inventor: Joseph S Podolski
  • Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
    Publication number: 20040171697
    Abstract: The present invention discloses compositions and methods useful for treating wasting, especially a loss of muscle mass. The present invention also discloses compositions and methods useful for treating lipodystrophy. The compositions and methods of the present invention are particularly beneficial to HIV-infected individuals.
    Type: Application
    Filed: November 12, 2003
    Publication date: September 2, 2004
    Applicant: ZONAGEN, INC.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • Methods for treatment of erectile dysfunction
    Publication number: 20040102475
    Abstract: Improved drug compositions and methods useful in the treatment of male erectile dysfunction. An optimized mixture of the drugs phentolamine mesylate, papaverine hydrochloride, and alprostadil in a buffer containing L-arginine and glycine is to be injected into the penile tissue to produce an erection in otherwise impotent men.
    Type: Application
    Filed: November 3, 2003
    Publication date: May 27, 2004
    Applicant: ZONAGEN, INC.
    Inventor: Joseph S. Podolski
  • Methods and compositions with trans-clomiphene
    Publication number: 20040097597
    Abstract: The present invention relates to the use of compositions comprising trans-clomiphene for treating men with hypogonadism. The invention is also directed to methods for treating males with hypogonadism. The present invention is also directed to methods of decreasing cholesterol levels.
    Type: Application
    Filed: April 30, 2003
    Publication date: May 20, 2004
    Applicant: Zonagen, Inc.
    Inventors: Joseph S. Podolski, Ronald Wiehle
  • Methods for treatment of male erectile dysfunction
    Patent number: 6696072
    Abstract: Improved drug compositions and methods useful in the treatment of male erectile dysfunction. An optimized mixture of the drugs phentolamine mesylate, papaverine hydrochloride, and alprostadil in a buffer containing L-arginine and glycine is to be injected into the penile tissue to produce an erection in otherwise impotent men.
    Type: Grant
    Filed: January 31, 2000
    Date of Patent: February 24, 2004
    Assignee: Zonagen, Inc.
    Inventor: Joseph S. Podolski
  • Combination therapy for modulating the human sexual response
    Publication number: 20030207891
    Abstract: The invention is directed to compositions and methods for modulating the human sexual response. The compositions comprise two or more pharmaceutically active agents which preferably include an alpha-adrenergic antagonist and a phosphodiesterase inhibitor.
    Type: Application
    Filed: June 17, 2003
    Publication date: November 6, 2003
    Applicant: Zonagen, Inc.
    Inventor: Joseph S. Podolski
  • Combination therapy for modulating the human sexual response
    Publication number: 20030004170
    Abstract: The invention is directed to compositions and methods for modulating the human sexual response. The compositions comprise two or more pharmaceutically active agents which preferably include an alpha-adrenergic antagonist and a phosphodiesterase inhibitor.
    Type: Application
    Filed: August 13, 2002
    Publication date: January 2, 2003
    Applicant: ZONAGEN, INC.
    Inventor: Joseph S. Podolski
  • Compositions for the treatment of male erectile dysfunction
    Patent number: 6482426
    Abstract: Improved drug compositions and methods useful in the treatment of male erectile dysfunction. An optimized mixture of the drugs phentolamine mesylate, papaverine hydrochloride, and alprostadil in a buffer containing L-arginine and glycine is to be injected into the penile tissue to produce an erection in otherwise impotent men.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: November 19, 2002
    Assignee: Zonagen, Inc.
    Inventor: Joseph S. Podolski
  • Materials and methods for immunocontraception
    Patent number: 6027727
    Abstract: A method for specifically inducing transient infertility or permanent sterility in a host animal by selective vaccination with specific zona pellucida proteins or immunocontraceptively active fragments thereof. Novel zona pellucida DNA sequences encoding specific zona pellucida proteins are disclosed.
    Type: Grant
    Filed: November 9, 1993
    Date of Patent: February 22, 2000
    Assignee: Zonagen, Inc.
    Inventors: Jeffrey D. Harris, Kuang T. Hsu, Joseph S. Podolski
  • DNAs encoding mammalian ZPBs
    Patent number: 6001599
    Abstract: A method for specifically inducing transient infertility or permanent sterility in a host animal by selective vaccination with specific zona pellucida proteins or immunocontraceptively active fragments thereof. Novel zona pellucida DNA sequences encoding specific zona pellucida proteins are disclosed.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: December 14, 1999
    Assignee: Zonagen, Inc.
    Inventors: Jeffrey D. Harris, Kuang T. Hsu, Joseph S. Podolski
  • Materials and methods for immunocontraception
    Patent number: 5989550
    Abstract: A method for specifically inducing transient infertility or permanent sterility in a host animal by selective vaccination with specific zona pellucida proteins or immunocontraceptively active fragments thereof. Novel zona pellucida DNA sequences encoding specific zona pellucida proteins are disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 23, 1999
    Assignee: Zonagen, Inc.
    Inventors: Jeffrey D. Harris, Kuang T. Hsu, Joseph S. Podolski
  • Mammalian ZPAs
    Patent number: 5981228
    Abstract: A method for specifically inducing transient infertility or permanent sterility in a host animal by selective vaccination with specific zona pellucida proteins or immunocontraceptively active fragments thereof. Novel zona pellucida DNA sequences encoding specific zona pellucida proteins are disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 9, 1999
    Assignee: Zonagen, Inc.
    Inventors: Jeffrey D. Harris, Kuang T. Hsu, Joseph S. Podolski
  • Chitosan induced immunopotentiation
    Patent number: 5980912
    Abstract: Methods and compositions for potentiating an immune response are disclosed which incorporate chitosan as an immunopotentiating adjuvant. Administration of the compositions of the invention is effected by various routes.
    Type: Grant
    Filed: March 25, 1997
    Date of Patent: November 9, 1999
    Assignee: Zonagen, Inc.
    Inventors: Joseph S. Podolski, Mitzi L. Martinez
  • ZPC polypeptides
    Patent number: 5976545
    Abstract: A method for specifically inducing transient infertility or permanent sterility in a host animal by selective vaccination with specific zona pellucida proteins or immunocontraceptively active fragments thereof. Novel zona pellucida DNA sequences encoding specific zona pellucida proteins are disclosed.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 2, 1999
    Assignee: Zonagen, Inc.
    Inventors: Jeffrey D. Harris, Kuang T. Hsu, Joseph S. Podolski
  • Chitosan induced immunopotentiation
    Patent number: 5965144
    Abstract: Methods and compositions for potentiating an immune response are disclosed which incorporate chitosan as an immunopotentiating adjuvant. Administration of the compositions of the invention is effected by various routes.
    Type: Grant
    Filed: April 24, 1998
    Date of Patent: October 12, 1999
    Assignee: Zonagen, Inc.
    Inventors: Joseph S. Podolski, Mitzi L. Martinez
  • Chitosan induced immunopotentiation
    Patent number: 5912000
    Abstract: Methods and compositions for potentiating an immune response are disclosed which incorporate chitosan as an immunopotentiating adjuvant. Administration of the compositions of the invention is effected by various routes.
    Type: Grant
    Filed: August 13, 1996
    Date of Patent: June 15, 1999
    Assignee: Zonagen, Inc.
    Inventors: Joseph S. Podolski, Kuang Hsu, Gurpreet Singh
  • Concentrated, substantially non-aggregated casein micelles as a fat/cream substitute and a method for reducing the fat content in food products
    Patent number: 5143741
    Abstract: Substantially non-aggregated casein micelles are employed as a fat substitute in food products. The concentrated casein micelles can replace all or a portion of the fat or cream in food products such as frozen dairy desserts, icings, puddings, whipped toppings, fortified skim milk, dips, spreads and sauces.
    Type: Grant
    Filed: October 30, 1991
    Date of Patent: September 1, 1992
    Inventors: Joseph S. Podolski, Maher Habib
  • Cream substitute ingredient and food products
    Patent number: 4985270
    Abstract: Non-fat and reduced fat whipped frozen dessert products wherein part or all of the milk fat, vegetable fat or oil ordinarily incorporated therein is replaced by a proteinaceous macrocolloid of, e.g., denatured whey protein particles or particles having a core of casein surrounded by a shell of denatured egg white protein. Illustrative embodiments include non-fat ice cream analog products having reduced calorie content, enhanced food value due to increased protein content, and possessing the physical and organoleptic character of full fat ice creams. The egg white protein/casein particles can be used also in sauces, dips, spreads, icing and cream pie fillings.
    Type: Grant
    Filed: September 19, 1988
    Date of Patent: January 15, 1991
    Assignee: The Nutrasweet Company
    Inventors: Norman Singer, Reed Wilcox, Joseph S. Podolski, Hsien-Hsin Chang, Suseelan Pookote, John M. Dunn, Leora Hatchwell